Reply to Letter to the Editor Regarding “Could Pretreatment Pan-Immune-Inflammation Value Predict Survival in Esophageal Cancer?”

Reply to Letter to the Editor Regarding “Could Pretreatment Pan-Immune-Inflammation Value Predict Survival in Esophageal Cancer?”

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgical oncology 2024-06, Vol.31 (6), p.3870-3871
Hauptverfasser: Feng, Jifeng, Chen, Qixun
Format: Artikel
Sprache:eng
Schlagworte:
Esophageal Neoplasms - mortality
Esophageal Neoplasms - pathology
Gastrointestinal Oncology
Humans
Inflammation
Medicine
Medicine & Public Health
Oncology
Prognosis
Surgery
Surgical Oncology
Survival Rate
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3871
container_issue 6
container_start_page 3870
container_title Annals of surgical oncology
container_volume 31
creator Feng, Jifeng
Chen, Qixun
description
doi_str_mv 10.1245/s10434-024-15101-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3052593092</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3052593092</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-a87047961f5505ed34a77d494a3b18ef2b2fe245ba026cac17d34f75f0fd39c13</originalsourceid><addsrcrecordid>eNp9kbtqHDEUhkVI8C1-ARdGkCaNHN1npgph2dgLCzHOpRXamaP1mBlpI2kM7tzkLeKX85NYm3USSJFKR9J3fonzIXTC6BnjUr1LjEohCeWSMMUoI_oFOmCqHElds5elpromDddqHx2mdEMpqwRVe2hf1KLRVNQH6McVbIY7nANeQs4Qt1W-Bjzv-hwivoK1jV3v1_jx_ucsTEOHLyPkCDaP4DO-tJ4sxnHyQBbeDXYcbe6Dx9_sMMEW7fo2489TvO1v7YB7j-cpbK7tGspuZn0L8f3j_cNr9MrZIcHx83qEvn6cf5ldkOWn88Xsw5K0gutMbF1RWTWaOaWogk5IW1WdbKQVK1aD4yvuoExmZSnXrW1ZVRBXKUddJ5qWiSP0dpe7ieH7BCmbsU8tDIP1EKZkynS4agRteEHf_IPehCn68rstxSrNuBaF4juqjSGlCM5sYj_aeGcYNVtJZifJFEnmlySjS9Ppc_S0GqH70_LbSgHEDkjlyq8h_n37P7FPk2-e1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3051761263</pqid></control><display><type>article</type><title>Reply to Letter to the Editor Regarding “Could Pretreatment Pan-Immune-Inflammation Value Predict Survival in Esophageal Cancer?”</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Feng, Jifeng ; Chen, Qixun</creator><creatorcontrib>Feng, Jifeng ; Chen, Qixun</creatorcontrib><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-024-15101-6</identifier><identifier>PMID: 38396038</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Esophageal Neoplasms - mortality ; Esophageal Neoplasms - pathology ; Gastrointestinal Oncology ; Humans ; Inflammation ; Medicine ; Medicine &amp; Public Health ; Oncology ; Prognosis ; Surgery ; Surgical Oncology ; Survival Rate</subject><ispartof>Annals of surgical oncology, 2024-06, Vol.31 (6), p.3870-3871</ispartof><rights>Society of Surgical Oncology 2024</rights><rights>Society of Surgical Oncology 2024.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-a87047961f5505ed34a77d494a3b18ef2b2fe245ba026cac17d34f75f0fd39c13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-024-15101-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-024-15101-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,782,786,27933,27934,41497,42566,51328</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38396038$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feng, Jifeng</creatorcontrib><creatorcontrib>Chen, Qixun</creatorcontrib><title>Reply to Letter to the Editor Regarding “Could Pretreatment Pan-Immune-Inflammation Value Predict Survival in Esophageal Cancer?”</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><subject>Esophageal Neoplasms - mortality</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Gastrointestinal Oncology</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Prognosis</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Survival Rate</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kbtqHDEUhkVI8C1-ARdGkCaNHN1npgph2dgLCzHOpRXamaP1mBlpI2kM7tzkLeKX85NYm3USSJFKR9J3fonzIXTC6BnjUr1LjEohCeWSMMUoI_oFOmCqHElds5elpromDddqHx2mdEMpqwRVe2hf1KLRVNQH6McVbIY7nANeQs4Qt1W-Bjzv-hwivoK1jV3v1_jx_ucsTEOHLyPkCDaP4DO-tJ4sxnHyQBbeDXYcbe6Dx9_sMMEW7fo2489TvO1v7YB7j-cpbK7tGspuZn0L8f3j_cNr9MrZIcHx83qEvn6cf5ldkOWn88Xsw5K0gutMbF1RWTWaOaWogk5IW1WdbKQVK1aD4yvuoExmZSnXrW1ZVRBXKUddJ5qWiSP0dpe7ieH7BCmbsU8tDIP1EKZkynS4agRteEHf_IPehCn68rstxSrNuBaF4juqjSGlCM5sYj_aeGcYNVtJZifJFEnmlySjS9Ppc_S0GqH70_LbSgHEDkjlyq8h_n37P7FPk2-e1Q</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Feng, Jifeng</creator><creator>Chen, Qixun</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20240601</creationdate><title>Reply to Letter to the Editor Regarding “Could Pretreatment Pan-Immune-Inflammation Value Predict Survival in Esophageal Cancer?”</title><author>Feng, Jifeng ; Chen, Qixun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-a87047961f5505ed34a77d494a3b18ef2b2fe245ba026cac17d34f75f0fd39c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Esophageal Neoplasms - mortality</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Gastrointestinal Oncology</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Prognosis</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feng, Jifeng</creatorcontrib><creatorcontrib>Chen, Qixun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feng, Jifeng</au><au>Chen, Qixun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply to Letter to the Editor Regarding “Could Pretreatment Pan-Immune-Inflammation Value Predict Survival in Esophageal Cancer?”</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2024-06-01</date><risdate>2024</risdate><volume>31</volume><issue>6</issue><spage>3870</spage><epage>3871</epage><pages>3870-3871</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>38396038</pmid><doi>10.1245/s10434-024-15101-6</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1068-9265
ispartof Annals of surgical oncology, 2024-06, Vol.31 (6), p.3870-3871
issn 1068-9265
1534-4681
language eng
recordid cdi_proquest_miscellaneous_3052593092
source MEDLINE; SpringerNature Journals
subjects Esophageal Neoplasms - mortality
Esophageal Neoplasms - pathology
Gastrointestinal Oncology
Humans
Inflammation
Medicine
Medicine & Public Health
Oncology
Prognosis
Surgery
Surgical Oncology
Survival Rate
title Reply to Letter to the Editor Regarding “Could Pretreatment Pan-Immune-Inflammation Value Predict Survival in Esophageal Cancer?”
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T07%3A06%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply%20to%20Letter%20to%20the%20Editor%20Regarding%20%E2%80%9CCould%20Pretreatment%20Pan-Immune-Inflammation%20Value%20Predict%20Survival%20in%20Esophageal%20Cancer?%E2%80%9D&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Feng,%20Jifeng&rft.date=2024-06-01&rft.volume=31&rft.issue=6&rft.spage=3870&rft.epage=3871&rft.pages=3870-3871&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-024-15101-6&rft_dat=%3Cproquest_cross%3E3052593092%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3051761263&rft_id=info:pmid/38396038&rfr_iscdi=true